Matches in Wikidata for { <http://www.wikidata.org/entity/Q91800917> ?p ?o ?g. }
Showing items 1 to 75 of
75
with 100 items per page.
- Q91800917 description "artículu científicu espublizáu n'abril de 2019" @default.
- Q91800917 description "scientific article published on 05 April 2019" @default.
- Q91800917 description "wetenschappelijk artikel" @default.
- Q91800917 description "наукова стаття, опублікована 5 квітня 2019" @default.
- Q91800917 name "Efficacy and Safety of BRAF Inhibitors With or Without MEK Inhibitors in BRAF-Mutant Advanced Non-Small-Cell Lung Cancer: Findings From a Real-Life Cohort" @default.
- Q91800917 name "Efficacy and Safety of BRAF Inhibitors With or Without MEK Inhibitors in BRAF-Mutant Advanced Non-Small-Cell Lung Cancer: Findings From a Real-Life Cohort" @default.
- Q91800917 type Item @default.
- Q91800917 label "Efficacy and Safety of BRAF Inhibitors With or Without MEK Inhibitors in BRAF-Mutant Advanced Non-Small-Cell Lung Cancer: Findings From a Real-Life Cohort" @default.
- Q91800917 label "Efficacy and Safety of BRAF Inhibitors With or Without MEK Inhibitors in BRAF-Mutant Advanced Non-Small-Cell Lung Cancer: Findings From a Real-Life Cohort" @default.
- Q91800917 prefLabel "Efficacy and Safety of BRAF Inhibitors With or Without MEK Inhibitors in BRAF-Mutant Advanced Non-Small-Cell Lung Cancer: Findings From a Real-Life Cohort" @default.
- Q91800917 prefLabel "Efficacy and Safety of BRAF Inhibitors With or Without MEK Inhibitors in BRAF-Mutant Advanced Non-Small-Cell Lung Cancer: Findings From a Real-Life Cohort" @default.
- Q91800917 P1433 Q91800917-DD15787F-23B0-4E10-8EC2-10D69D217234 @default.
- Q91800917 P1476 Q91800917-13D915B4-FF7E-41C6-9480-0C1BE44794F4 @default.
- Q91800917 P2093 Q91800917-0D52E72A-78EA-428F-ACEF-AB9B76BCCE8A @default.
- Q91800917 P2093 Q91800917-2C897588-6B08-44D8-86D9-F3AF3DBF51C3 @default.
- Q91800917 P2093 Q91800917-30899379-EA55-4D83-807F-0D7CC47DF1B8 @default.
- Q91800917 P2093 Q91800917-58E6D327-C6ED-470E-BAB7-BF249BA91E5D @default.
- Q91800917 P2093 Q91800917-63E30E33-8F76-4271-B80C-1791FF7E278C @default.
- Q91800917 P2093 Q91800917-6D143C00-045F-4208-9FC1-4D9352F7EE63 @default.
- Q91800917 P2093 Q91800917-74B0B099-BB0D-4D8F-B75E-0F2ABDB80678 @default.
- Q91800917 P2093 Q91800917-7EA8AE7F-230E-4E0E-865E-C2DE44C83E8D @default.
- Q91800917 P2093 Q91800917-8BD3C856-4A99-4685-B886-14A5BC0D4BDD @default.
- Q91800917 P2093 Q91800917-8CA0DF67-D99F-4287-B962-66F983842631 @default.
- Q91800917 P2093 Q91800917-927412AA-E63F-46E8-BE7F-E9CE818EEEB8 @default.
- Q91800917 P2093 Q91800917-9A69A31D-1921-40F7-9860-98CBD8E62570 @default.
- Q91800917 P2093 Q91800917-A75ED4D9-3418-44A6-818E-6CB1B568283D @default.
- Q91800917 P2093 Q91800917-A7D9CAB6-1002-4C9B-A896-4E48E9843C06 @default.
- Q91800917 P2093 Q91800917-C1E8050A-1F76-4F25-B329-E5B989E74757 @default.
- Q91800917 P2093 Q91800917-D0194B2B-875B-4311-A3AC-F9AC0C34BDA8 @default.
- Q91800917 P2093 Q91800917-D5AA222A-3682-4755-AE3E-5396E8399E6D @default.
- Q91800917 P2093 Q91800917-E0578D97-C63E-4F13-9CB6-D7E51C427601 @default.
- Q91800917 P2093 Q91800917-E155DAA7-69E7-4835-8BAE-9DB260DE55F6 @default.
- Q91800917 P2093 Q91800917-FBFCB02A-DB51-4422-BA56-727BD3511DBF @default.
- Q91800917 P304 Q91800917-527366AC-6323-4A2E-9C30-C75585CEEBA1 @default.
- Q91800917 P31 Q91800917-82CBDDB6-9F14-466F-B5B1-D6E07C298348 @default.
- Q91800917 P356 Q91800917-536AEB62-0032-42F3-A08F-61547FA7FC02 @default.
- Q91800917 P433 Q91800917-7B7C8A96-520F-4FAD-88AE-707C013475FA @default.
- Q91800917 P478 Q91800917-0F5F4E1A-BB7E-4FCE-99B8-0FBD5FC2CA1F @default.
- Q91800917 P50 Q91800917-59D4688B-1D38-4D7E-BBF1-CF2A02311B42 @default.
- Q91800917 P50 Q91800917-B479A174-A5AE-4F52-82DB-0140C9497B40 @default.
- Q91800917 P577 Q91800917-728DFB6E-C7A9-408A-B1FB-52FBA6C02D48 @default.
- Q91800917 P698 Q91800917-35443B84-836E-4259-9439-7BFDCDF6E05D @default.
- Q91800917 P356 J.CLLC.2019.03.007 @default.
- Q91800917 P698 31060855 @default.
- Q91800917 P1433 Q332299 @default.
- Q91800917 P1476 "Efficacy and Safety of BRAF Inhibitors With or Without MEK Inhibitors in BRAF-Mutant Advanced Non-Small-Cell Lung Cancer: Findings From a Real-Life Cohort" @default.
- Q91800917 P2093 "Abed Agbarya" @default.
- Q91800917 P2093 "Aharon Yonathan Cohen" @default.
- Q91800917 P2093 "Alona Zer" @default.
- Q91800917 P2093 "Damien Urban" @default.
- Q91800917 P2093 "Elias Bshara" @default.
- Q91800917 P2093 "Elizabeth Dudnik" @default.
- Q91800917 P2093 "Hovav Nechushtan" @default.
- Q91800917 P2093 "Israel Lung Cancer Group" @default.
- Q91800917 P2093 "Jair Bar" @default.
- Q91800917 P2093 "Mira Wollner" @default.
- Q91800917 P2093 "Mor Moskovitz" @default.
- Q91800917 P2093 "Moshe Mishaeli" @default.
- Q91800917 P2093 "Natalie Maimon Rabinovich" @default.
- Q91800917 P2093 "Nir Peled" @default.
- Q91800917 P2093 "Noa Popovits-Hadar" @default.
- Q91800917 P2093 "Ofer Rotem" @default.
- Q91800917 P2093 "Ronen Brenner" @default.
- Q91800917 P2093 "Shoshana Keren" @default.
- Q91800917 P2093 "Teodor Kuznetsov" @default.
- Q91800917 P2093 "Tzippy Shochat" @default.
- Q91800917 P304 "278-286.e1" @default.
- Q91800917 P31 Q13442814 @default.
- Q91800917 P356 "10.1016/J.CLLC.2019.03.007" @default.
- Q91800917 P433 "4" @default.
- Q91800917 P478 "20" @default.
- Q91800917 P50 Q57081480 @default.
- Q91800917 P50 Q89538379 @default.
- Q91800917 P577 "2019-04-05T00:00:00Z" @default.
- Q91800917 P698 "31060855" @default.